DHFB
CVS icon

Dixon Hubard Feinour & Brown’s CVS Health CVS Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$9.82M Sell
105,953
-624
-0.6% -$60.9K 1.17% 23
2022
Q1 		$10.8M Buy
106,577
+1,417
+1% +$149K 1.08% 29
2021
Q4 		$10.8M Buy
105,160
+6,646
+7% +$614K 1.04% 33
2021
Q3 		$8.36M Sell
98,514
-1,248
-1% -$105K 1.77% 19
2021
Q2 		$8.32M Buy
+99,762
New +$8.17M 1.73% 18
2016
Q3 		– Sell
-73,425
Closed -$7.03M – 171
2016
Q2 		$7.03M Sell
73,425
-1,522
-2% -$152K 2.25% 5
2016
Q1 		$7.53M Sell
74,947
-1,681
-2% -$163K 2.46% 3
2015
Q4 		$7.49M Buy
76,628
+255
+0.3% +$25K 2.38% 7
2015
Q3 		$7.37M Buy
76,373
+1,097
+1% +$115K 2.71% 6
2015
Q2 		$7.89M Sell
75,276
-3,199
-4% -$327K 2.43% 5
2015
Q1 		$8.1M Sell
78,475
-3,018
-4% -$305K 2.39% 6
2014
Q4 		$7.85M Sell
81,493
-760
-0.9% -$67K 2.44% 4
2014
Q3 		$6.55M Sell
82,253
-825
-1% -$65K 2.15% 6
2014
Q2 		$6.26M Sell
83,078
-2,105
-2% -$159K 2.05% 9
2014
Q1 		$6.38M Buy
85,183
+700
+0.8% +$49.4K 2.21% 4
2013
Q4 		$6.05M Sell
84,483
-1,957
-2% -$126K 2.23% 6
2013
Q3 		$4.91M Buy
86,440
+125
+0.1% +$7.45K 2.08% 8
2013
Q2 		$4.93M Buy
+86,315
New +$5M 2.2% 9

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dixon Hubard Feinour & Brown's CVS Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown reduced its CVS Health (CVS) stake by 0.59% in Q2 2022, selling an estimated $60.9K and leaving 105,953 shares worth $9.82M. The position accounts for 1.17% of the portfolio, ranked #23.

Dixon Hubard Feinour & Brown first reported a position in CVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $10.8M in Q4 2021. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Dixon Hubard Feinour & Brown held 105,953 shares of CVS Health worth $9.82M as of Q2 2022.
  • Dixon Hubard Feinour & Brown sold 624 CVS Health shares in Q2 2022, an estimated $60.9K.
  • CVS Health made up 1.17% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #23 holding.
  • Dixon Hubard Feinour & Brown first reported a position in CVS Health in Q2 2013 and has held it in 18 quarters since.
  • Dixon Hubard Feinour & Brown's CVS Health position peaked at $10.8M in Q4 2021.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.